NASDAQ:ONEM - 1Life Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $37.08
  • Forecasted Upside: 3.16 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$35.94
▲ +1.12 (3.22%)
1 month | 3 months | 12 months
Get New 1Life Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONEM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$37.08
▲ +3.16% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for 1Life Healthcare in the last 3 months. The average price target is $37.08, with a high forecast of $44.00 and a low forecast of $24.00. The average price target represents a 3.16% upside from the last price of $35.94.
Buy
The current consensus among 12 polled investment analysts is to buy stock in 1Life Healthcare.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/8/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/3/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/3/2020

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/11/2020Smith Barney CitigroupBoost Price Target$38.00 ➝ $42.00Low
i
11/11/2020Canaccord GenuityBoost Price TargetBuy$39.00 ➝ $41.00Low
i
Rating by Richard Close at Canaccord Genuity
11/11/2020JPMorgan Chase & Co.Reiterated RatingOverweight$40.00 ➝ $43.00High
i
11/11/2020Credit Suisse GroupBoost Price TargetOutperform$37.00 ➝ $40.00High
i
11/11/2020Piper SandlerBoost Price TargetOverweight$43.00 ➝ $44.00Medium
i
11/11/2020SVB LeerinkBoost Price TargetMarket Perform$36.00 ➝ $38.00High
i
Rating by D. Ha at SVB Leerink LLC
11/11/2020Morgan StanleyBoost Price TargetOverweight$35.00 ➝ $41.00High
i
10/30/2020Credit Suisse GroupInitiated CoverageOutperform$37.00High
i
10/14/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$37.00High
i
8/14/2020TruistBoost Price Target$30.00 ➝ $36.00Medium
i
8/13/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$23.00 ➝ $28.00Medium
i
Rating by Jamie Stockton at Wells Fargo & Company
7/17/2020Piper SandlerBoost Price TargetOverweight$40.00 ➝ $43.00Medium
i
Rating by Sean Wieland at Piper Sandler
7/8/2020CitigroupBoost Price TargetPositive ➝ Neutral$20.00 ➝ $38.00Low
i
Rating by Ralph Giacobbe at Citigroup Inc.
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$36.00Medium
i
Rating by D. Ha at SVB Leerink LLC
6/30/2020Piper SandlerBoost Price TargetOverweight$29.00 ➝ $40.00High
i
Rating by Sean Wieland at Piper Sandler
6/19/2020Canaccord GenuityInitiated CoverageBuy$39.00High
i
5/18/2020Morgan StanleyBoost Price TargetOverweight$21.00 ➝ $35.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
5/14/2020SunTrust BanksBoost Price TargetBuy$26.00 ➝ $30.00Medium
i
Rating by Sandy Draper at SunTrust Banks, Inc.
5/14/2020Piper SandlerReiterated RatingOverweight$27.00 ➝ $29.00High
i
Rating by Sean Wieland at Piper Sandler
5/14/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$18.00 ➝ $23.00High
i
Rating by Jamie Stockton at Wells Fargo & Company
4/1/2020CitigroupLower Price TargetNeutral$25.00 ➝ $20.00High
i
Rating by Ralph Giacobbe at Citigroup Inc.
3/19/2020Morgan StanleyLower Price TargetOverweight$27.00 ➝ $21.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
2/25/2020Morgan StanleyInitiated CoverageOverweight$27.00High
i
2/25/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$24.00High
i
2/25/2020Robert W. BairdInitiated CoverageNeutral$24.00High
i
2/25/2020JPMorgan Chase & Co.Initiated CoverageOverweight$28.00High
i
2/25/2020SunTrust BanksInitiated CoverageBuy$30.00High
i
2/25/2020CitigroupInitiated CoverageNeutral$25.00High
i
2/25/2020William BlairInitiated CoverageOutperformHigh
i
Rating by R. Daniels at William Blair
2/25/2020Piper SandlerInitiated CoverageOverweight$29.00High
i
(Data available from 12/3/2015 forward)
1Life Healthcare logo
1Life Healthcare, Inc. operates a membership-based primary care platform. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2019, it had approximately 422,000 members in nine markets in the United States; and 7,000 enterprise clients. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $35.94
$34.75
$36.15

50 Day Range

MA: $32.15
$28.21
$36.00

52 Week Range

Now: $35.94
$15.00
$44.87

Volume

1,304,654 shs

Average Volume

1,521,759 shs

Market Capitalization

$4.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A